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Objective—Arteriogenesis, the development of a collateral circulation, is important for tissue survival but remains
functionally defective because of early normalization of fluid shear stress (FSS). Using a surgical model of
chronically elevated FSS we showed that rabbits exhibited normal blood flow reserve after femoral artery ligature
(FAL). Inhibition of the Rho pathway by Fasudil completely blocked the beneficial effect of FSS. In a
genome-wide gene profiling we identified actin-binding Rho activating protein (Abra), which was highly
upregulated in growing collaterals.
Methods and Results—qRT-PCR and Western blot confirmed highly increased FSS-dependent expression of Abra in
growing collaterals. NO blockage by L-NAME abolished FSS-generated Abra expression as well as the whole
arteriogenic process. Cell culture studies demonstrated an Abra-triggered proliferation of smooth muscle cells through
a mechanism that requires Rho signaling. Local intracollateral adenoviral overexpression of Abra improved collateral
conductance by 60% in rabbits compared to the natural response after FAL. In contrast, targeted deletion of Abra in
CL57BL/6 mice led to impaired arteriogenesis.
Conclusions—FSS-induced Abra expression during arteriogenesis is triggered by NO and leads to stimulation of collateral
growth by smooth muscle cell proliferation. (Arterioscler Thromb Vasc Biol. 2009;29:2093-2101.)
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The vascular system has the capacity to heal itself by thedevelopment and growth of a collateral circulation. In
fact, the deleterious effects of arterial occlusions can be
partially compensated, especially when the speed of occlu-
sion is not acute but somewhat delayed. We and others have
shown that the degree of compensation by collateral vessels,
even when they have matured after a period of rapid growth,
reaches only about 40% of the maximal conductance of the
artery they had replaced.1,2 Fluid shear stress initiates the
activation of endothelial cells and modulates processes,
which control attraction of circulating cells to the collateral
wall.3 Monocytes were shown to play a pivotal role during
arteriogenesis.4,5
Further elucidation of the molecular pathways leading to a
functional “natural bypass” could be the basis for stimulating
the nonoptimal processes to produce full restoration of
arterial function.
The undisturbed arteriogenic process only leads to an
incomplete restoration of function, probably because of the
early restoration of fluid shear stress (FSS), which is
related to the cube root of the expanding radius. This early
growth-induced decline of the FSS level was prevented in
a previous experiment by creating an arterio-venous (AV)-
shunt to drain most of the collateral flow into the venous
system3,6 thereby reestablishing a method invented by
Holman in 1949.7 As a consequence, a long-lasting growth
of collateral vessels completely restored (and overshot)
physiological function of the occluded artery. However,
the Rho kinase inhibitor Fasudil abolished the shunt effect
completely.6
In a genome-wide screening of mRNA abundance in
growing collaterals of rats we identified actin-binding Rho
activating protein (Abra). Abra (also known as Stars) is a
muscle specific actin-binding protein capable of stimulating
SRF-dependent transcription through a mechanism involving
RhoA and actin polymerization.8 In cardiac tissue Abra
mRNA is upregulated in response to pressure overload.8,9
Recently it was shown that Abra is involved in human
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skeletal muscle hypertrophy and atrophy.10 Forced overex-
pression of Abra in mouse heart tissue results in an increased
sensitivity to biomechanical stress stimuli leading to cardiac
hypertrophy.11 However, its role in blood vessels has not been
determined. In light of the requirement of Rho signaling
during arteriogenesis, we hypothesized that a fluid shear
stress–induced upregulation of Abra initiates collateral re-
modeling. To test this hypothesis, the upregulation in grow-
ing collaterals was confirmed by independent techniques like
qRT-PCR and Western Blot. With the objective to explore the
cellular localization of Abra in the vascular wall we per-
formed in situ hybridization and immunohistochemistry. The
stimulating effect of Abra on cultured vascular cells was
examined in a proliferation assay. Subsequently, we quanti-
fied the arteriogenic response in vivo after a local adenoviral
overexpression in rabbits as well as a targeted deletion of
Abra in mice.
Our findings suggest an important role of Abra during
the initiation of arteriogenesis. The previously described
features of Abra could in part be extended to arteriogen-
esis. Finally we propose a position for the novel arterio-
genesis gene in the existing arteriogenesis pathways and
thereby we contribute to a more comprehensive under-
standing of the process.
Methods
An extended methods section is available in the supplemental
materials (available online at http://atvb.ahajournals.org).
Animal Models
The study was performed according to Section 8 of the German Law
for the Protection of Animals, which confirms to the U.S. National
Institutes of Health (NIH) guidelines.
New Zealand White rabbits (Charles Riber, Kissleg, Gergmany)
were used for hemodynamic analyses. Spraque Dawley rats (Harlan
Winkelmann, Borchen, Germany) served as a model for the genome-
wide expression studies, and Abra/ mice (a kind gift from Dr E.
Olsen, University of Texas Southwestern Medical Center, Dallas,
Texas) were used to study the arteriogenic effect of targeted deletion
of the Abra gene.
Cell Culture, Proliferation Assay
Porcine aortic endothelial cells (PAECs) were obtained from the
aorta as previously described.12 To investigate proliferative activity
the MTT Cell Proliferation Assay (ATCC) was used.
RNA Isolation, Quantitative Real-Time PCR, and
Microarray Analysis
Seven days after surgery total RNA was isolated (RNeasy Mini
kit, Qiagen) from dissected collaterals or other organs. qRT-PCR
was performed, and the relative amount of target mRNA normal-
ized to 18S RNA was calculated as previously described.13
The data discussed in this publication have been deposited inNCBIs
Gene Expression Omnibus14 and are accessible through GEO Series
accession number GSE16359. (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?accGSE16359).
Adenoviral Production
Recombinant adenoviruses expressing Abra were generated using
the ViraPower Adenoviral Expression system (Invitrogen). Ad-
enoviral plasmids were transfected into 293A cells using Meta-
fectene (Biontex). Adenovirus was purified from the cells using
the Vivaspin kit (Vivascience). Titer-estimation was performed
using QuickTiter Adenovirus Titer Immunoassay Kit (Cell Bio-
labs Inc).
In Situ Hybridization
DIG-labeled RNA probes corresponding to the sense and anti-
sense strand of the Abra cDNA were prepared by in vitro
transcription using DIG RNA Labeling Kit SP6/ T7 (Roche)
according to the manufacturers’ protocol. In situ hybridization
was performed on paraffin sections of the rat M. quadriceps as
described.15 Detection was done with anti-DIG antibody (Roche)
and visualized by NBT/BCIP staining (Roche). Sections were
counterstained with eosin.
Western Blot Analysis
Western blotting was performed on protein extracts of collateral
vessels or cultured cells with specific antibodies as described
previously.16 Used antibodies and concentrations: Abra 1:500 (Dav-
ids Biotechnologie, from chicken for PAECs and tissue, from rabbit
for PSMCs), Vinculin 1:800 (Sigma).
Immunohistochemistry
Immunostaining was performed as previously described.17 Sections
were viewed with a confocal microscope (Leica TCS SP).
Statistical Analysis
All values are expressed as meanSEM. Two treatment groups were
compared by the unpaired Student t test. One-way ANOVA (Prism,
GraphPad Software Inc) was performed for maximum collateral
conductances. Probability values less than 0.05 were considered as
statistically significant.
Results
Actin-Binding Rho-Activating Protein (Abra) Is
Upregulated in FSS-Stimulated Collateral Arteries
To analyze the gene expression pattern of FSS-induced
collateral growth we adapted the arterio-venous (AV)-shunt
model to rats. Animals were subjected to femoral artery
ligature (FAL) in both legs and a one-sided additional
AV-shunt for increased FSS in the collateral arteries. In
search for genes that may be involved in the mediation of
FSS-induced arteriogenesis, we performed gene expression
profiling of growing collaterals in rats using microarray
analysis.
A large set of reproducibly differential genes was detected
at high statistical significance between sham-treated and
shunt-treated collateral arteries. A heat map shows the repro-
ducibility of these findings between the different individual
arteries that constitute the 2 different groups. Hierarchical
clustering of the top 100 of the most differential genes
between sham and shunt treated collateral arteries is given in
supplemental Figure I. A subset of 354 transcripts demon-
strating statistically significant differences (log2 ratio4.0 or
4.0, P0.05) in abundance between AV-shunt and sham
collaterals was used for pathway analysis. Gene Set Enrich-
ment Analysis (GSEA)18 and Kyoto Encyclopedia of Genes
and Genomes (KEGG, http://www.genome.jp/kegg/) showed
an enrichment of transcripts displaying a role in remodeling
of the actin cytoskeleton, an activation of the Rho/ROCK-
pathway and the calcium signaling pathway (supplemental
Table II).
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One of the most upregulated genes was Abra (Figure
1A). qRT-PCR confirmed upregulation of Abra, RhoA,
serum response factor (SRF), and Tmsb4 in growing
collateral vessels. Smoothelin, a marker for SMC differ-
entiation, was significantly downregulated in shunt collat-
erals (Figure 1B).
The amount of Abra transcripts in the surrounding skeletal
muscle was unchanged in control-, ligature-, or shunt-treated
animals (Figure 1C). Furthermore, we tested rat aortic smooth
muscle cells (RASMCs), which were exposed to cyclic
stretch for 0.5 to 24 hours, for Abra mRNA abundance and
did not find any difference when compared to untreated
controls (supplemental Figure II).
Abra Is Expressed in Blood Vessels
In contrast to the previously identified restriction of
endogenous Abra to cardiac and skeletal muscle,8 we
demonstrated that Abra is also transcribed in blood vessels
using gene-specific primers for end point PCR. To exclude
striated muscle contamination we investigated also those
arteries which are not surrounded by skeletal muscle. Abra
transcripts were detected in the heart, quadriceps muscle,
and in all examined arteries such as the aorta, iliac arteries,
and small collateral vessels (Figure 2A). The cellular
localization in the vessel wall was studied by in situ
hybridization with a DIG-labeled Abra RNA antisense
probe on paraffin sections of quadriceps muscles of rats.
mRNA transcripts were detected in the collateral vessels 7
days after AV-shunt treatment in ECs as well as in SMCs
(Figure 2B). We immunostained cryosections of collateral
arteries of the quadriceps muscle to correlate the new
transcriptional localization with the corresponding protein
expression. The specificity of the antibody was confirmed
by the lack of signal when Abra peptide, used for the
generation of the antiserum, was added before staining. In
the Western Blot, a specific signal appeared in COS1 cells
transfected with Abra carrying plasmid. Previous observa-
tions of a partial overlap of the Z-line in longitudinal
sections of skeletal muscle could be confirmed by coim-
munostaining with anti-Abra and anti -actinin (supple-
mental Figure III).
In the vasculature, Abra protein was mainly present in
the cytosol of SMCs and in the nuclei of ECs. (Figure 2C).
In Western Blot as well as when comparing cross-sections
of collaterals of shunt treated or FAL treated rats, highest
Abra expression was also found after shunt treatment.
To examine the transmission of FSS exposed to the
endothelium to Abra expression in the media, shunt treated
rats received L-NAME (30 mg/kg BW/d) in the drinking
water. The blockage of all isoforms of NO synthases
abolished the stimulatory effect of FSS on collateral
growth (Figure 2E) and resulted in completely repressed
Abra transcription (Figure 2F) providing a potential trans-
duction mechanism of FSS.
Abra Overexpression Induces Proliferation Activity
of SMCs via Rho/ROCK
A crucial process during arteriogenesis is increased prolifer-
ation mainly of SMCs but also of ECs. Therefore we
investigated whether Abra overexpression triggers prolifera-
Figure 1. A, Log2-ratio vs Log2-intensity plot of Microarray data of shunt
versus sham collaterals 7 days after surgery. Selected genes are high-
lighted. Note, Abra is one of the most upregulated genes, which was
reconfirmed by B. qRT-PCR of selected genes of rat collateral arteries C,
Abra mRNA abundance in quadriceps muscles of rats.
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tive and metabolic activity of SMCs and ECs using MTT cell
proliferation assay.
Abra overexpressing porcine SMCs showed a 47.5%
increase of relative proliferative activity on day 2
(P0.05) compared to Ad_LacZ–transduced controls
(n8). On day 3 the proliferative activity was almost
doubled (90%, P0.01). Rho kinase inhibitor Fasudil
inhibited Abra-induced proliferative activity, indicating an
involvement of Rho signaling in the process (Figure 3A).
In contrast, porcine aortic endothelial cells (PAECs) in
culture did not show significant changes in proliferation
activity after Abra transduction compared to Ad_LacZ
controls on day 2 and 3 (Figure 3B). In both experiments,
immunostaining and Western Blot confirmed recombinant
Abra expression (supplemental Figure IV). Proliferative
activity in Abra-transduced SMCs was confirmed in an
A10 rat cell line (supplemental Figure V).
Abra Modulation In Vivo by a Local
Intracollateral Adenoviral Gene Transfer
To address the functional implications of Abra on arteriogenesis
in vivo we modulated its expression by adenoviral gene transfer.
A recombinant Abra adenovirus under the control of a CMV
promoter (Ad_Abra) was locally injected into the collaterals of
rabbits. These experiments were done after an initial FAL
without AV-shunt treatment to investigate whether gene transfer
of Abra alone can substitute for the effect of FSS.
Virus solution was injected into the collateral system of the
rabbit hindlimb. A temporary occlusion proximal of the
ligature interrupted the blood flow and allowed the virus to
incubate for 30 minutes inside the collateral arteries before it
Figure 2. A, Abra mRNA detection by end point PCR in rat tissue
(L indicates ligature; C, untreated control). B, Cellular localization of
Abra transcripts by in situ hybridization of shunt treated collateral
vessels in rats. (AS indicates antisense probe; S, sense probe.
Scale bars20 m) C, Cross sections of rat collateral vessels 7
days after indicated treatment (Abra, green; SMA, red; scale
bars30 m). Arrows in magnifications of micrographs depict
nuclear localization of Abra in endothelial cells. D, Western blot
analysis of Abra protein abundance in rat collaterals 7 days after
surgery. Membranes were reprobed for Vinculin to ensure equal
loading. E, Representative angiographies of rat hindlimbs 7 days
after indicated treatment. F, Effect of indicated treatment on Abra
transcription in rat collateral arteries.
Figure 3. A, Proliferation activity of Abra-transduced porcine
SMCs (PSMCs) showed a significant increase of MTT activity
after 3 days (90%) which could be abolished by Fasudil. B,
Abra-transduced ECs did not show increased proliferation
activity compared to Ad_LacZ controls (values are given in
meanSEM, n8; *P0.05; **P0.01 vs Ad_LacZ).
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was opened again (Figure 4A). A transgene specific RT-PCR
confirmed a local restriction to the site of transduction. Viral
transcripts were detected in the collaterals of the virus side
(VC) but not in those tissues of the control ligated side (LC).
An accumulation of excessive virus was observed in the
spleen. No Abra viral transcripts appeared in collaterals of
Ad_LacZ treated rabbits (Figure 4B).
A maximum of 2.5-fold forced local overexpression of Abra
could be reached by 41010 ifu of Ad_Abra (Figure 4C; n3).
This resulted in a significant improvement of maximum collat-
eral conductance to 230.118.6 mL/min/100 mm Hg (versus
Ad_LacZ: 14410.6 mL/min/100 mm Hg) 7 days after gene
transfer, which represents a partial substitution of the effect of
AV-Shunt treatment (30615 mL/min/100 mm Hg; Figure 4D).
Corresponding angiographies of virus-treated rabbit hindlimbs
illustrate the collateral growth caused by Abra overexpression
(Figure 4E).
Arteriogenesis Is Impaired in Mice Lacking Abra
To test the “loss of function” we investigated the arteriogenic
response of Abra/ mice. Targeted deletion was confirmed
by the lack of Abra mRNA in homozygous mutant skeletal
muscles by RT-PCR (Figure 5A). Quantification of tissue
perfusion in the distal hindlimbs of femoral artery ligated
Abra/ mice or nontransgenic littermates (wild-type, WT)
by Laser Doppler blood flow demonstrated an impaired
arteriogenesis in Abra/ mice.
In both, Abra/ and WT mice (n15) with the CL57BL/6
background, right to left ratio decreased immediately after
occlusion (1.010.02 to 0.080.009 [Abra/] versus
1.010.017 to 0.080.009 [WT]). A continuous blood flow
recovery to up to 91% was observed during the whole
observation period of 3 weeks in control animals, whereas
Abra/ did not further improve 59% of blood flow recovery
after 14 days (Figure 5B and 5C).
To define whether Abra contributes to angiogenesis or collat-
eral growth in our model we studied collateral anatomy in the
complete adductor muscle of WT or Abra mice and performed
morphometry: Diameter (46.33.4 m versus 48.82.8 m),
wall area (1076154 m2 versus 1123167 m2), and wall
area of preexisting arterioles did not differ between WT and
Abra/ mice. Collateral diameter was increased after 21 days
of ligature in both groups, but in Abra/mice the diameter was
significantly smaller than in WT (Abra/: 65.22.2 m; WT:
77.03.5 m). Even more notable, 21 days after ligature,
collateral wall area did not increase in Abra/ mice at all but
significantly differed from WT (1397129 versus
1861182 m2, P0.01; Figure 5D). These findings confirmed
the above perfusion data and indicate an incomplete regeneration
of collateral arteries in Abra-deficient mice.
Capillary density in the calf muscle was also assessed and
provided additional evidence for the arteriogenesis-
specificity of our hindlimb model. In calf muscles of unli-
gated WT mice capillary density was 1.670.14 (in capillary/
fiber) and 1.740.12 in unligated Abra/. 21 days after
ligation the capillary/fiber ratio in calf muscles showed a
slight but insignificant increase in both groups (WT:
1.780.05; KO: 1.820.12) suggesting the absence of an
angiogenic stimulus in these mice (Figure 5D).
Abra-Induced Rho Signaling and Actin Dynamics
in FSS-Induced Arteriogenesis
To correlate Abra overexpression with changes in RhoA
expression, we probed for RhoA expression in FSS-
stimulated and Abra-overexpressing collateral vessels of rats
as well as in Abra-deficient mice. Representative micro-
graphs illustrate increased RhoA expression after shunt sur-
gery, which can also be induced by forced adenoviral Abra
overexpression (Figure 6A). Contrary to that, RhoA is de-
creased in Abra-deficient mice (Figure 6B).
To determine actin polymerization in FSS-induced arte-
riogenesis we performed a specific staining for G-actin and
F-actin in shunt-treated collateral arteries. As expected, the
dedifferentiated state of SMCs is characterized by a
decrease in F-actin and an increase in G-actin (Figure 6C).
Discussion
We have identified Abra as a novel initial regulator of
arteriogenesis. In a rat model of chronically elevated fluid
shear stress (FSS) Abra is upregulated in growing collaterals.
The results of our present study show that a local intracollat-
eral adenoviral overexpression of Abra improves collateral
conductance after FAL in rabbits. Targeted deletion of Abra
in mice leads to impaired arteriogenesis.
It is known that among the physical forces that control the
size of the arterial tree, FSS is the most important one.19–23
We have recently developed a new small animal model
(reminiscent of a large-animal experiment reported already in
Figure 4. A, Scheme of local adenoviral gene transfer in the col-
lateral circulation of the rabbit hindlimb. B, Transgene specific
RT-PCR of RNA from either Ad_Abra– or Ad_LacZ–transduced
rabbit organs (collaterals of the virus side [VC), collaterals of the
ligated side [LC], spleen [Sp], Liver [Li], left ventricle [LV], right
ventricle [RV]). C, qRT-PCR showing Abra mRNA abundance of
isolated collaterals of either Ad_Abra– or Ad_LacZ– (41010 ifu)
treated rabbits in comparison to shunt collaterals (n3). D, Max-
imum collateral conductance (CCmax) in rabbit hindlimbs after
indicated treatments (Values are given in meanSEM, n6,
**P0.01). E, Representative angiographies of rabbit hindlimbs 7
days after indicated treatment.
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1949 by Holman7), where FSS was maximized by creating an
arterio-venous shunt between the distal stump of the occluded
femoral artery and the accompanying vein.3,24 In the present
study we tried to elucidate the regulators/mediators of collat-
eral growth initiated by high fluid shear stress. In a compar-
ative study we analyzed gene expression pattern of collateral
arteries of rats subjected to shunt treatment and preexistent
collateral arteries.
We selected differentially expressed Abra, a muscle-
specific actin-binding protein capable of stimulating SRF-
dependent transcription through a mechanism involving
RhoA and actin polymerization,8 which we found to be 7-fold
overexpressed (qRT-PCR) in growing collateral arteries. This
is interesting in the light of previous findings that Abra is
stress-inducible and markedly upregulated during hypertro-
phic growth of the heart in response to calcineurin activation
as well as pressure overload.8,9 Its subcellular localization in
the Z-line of the sarcomere suggests a stress-dependent
control of expression,8 and therefore we hypothesized a
potential involvement of Abra during the FSS-induced stim-
ulation of arteriogenesis. In the present study we could assign
a novel localization and a new function to Abra, thereby
enlarging the previously described restriction to striated
muscle. Under conditions of high shear stress Abra is strongly
upregulated, both on the transcriptional as well as on the
translational level in the cytoplasm of smooth muscle cells of
growing collaterals. A minor degree of FSS induced overex-
pression is also found in the endothelium. Our claim that
Abra is induced by FSS is supported by the observation that
rat aortic smooth muscle cells (RASMCs), which were
exposed to cyclic stretch for 0.5 to 24 hours, do not respond
with altered Abra mRNA abundance.
To investigate the functional role of Abra during arterio-
genesis we modulated its expression. Here we show that Abra
overexpression stimulates SMC proliferation in culture. Abra
may act as a direct SMC mitogen or it contributes indirectly
Figure 5. A, End point RT-PCR from RNA
of skeletal muscle showing no Abra tran-
scripts in Abra(/) mice compared to
nontransgenic littermates (/). NTC
indicates no template control. B, Impaired
blood flow recovery in right femoral artery
ligated Abra/ mice, expressed as Laser
Doppler perfusion right to left ratio. (Val-
ues are given in meanSEM; *P0.05 vs
WT) C, Representative color-coded laser
Doppler perfusion images. D, Morphomet-
ric measurements of collateral arteries
and capillaries in gene-targeted mice (n
15; values are given in meanSEM;
##P0.01 vs WT, ***P0.001, **P0.01,
*P0.05 vs preexistent).
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to a reprogramming of a distinct growth phenotype charac-
terized by the ability to replicate in an autonomous mitogen-
independent manner as it was shown for embryonic aortic
SMCs in culture.25,26
Adenoviral overexpression of Abra in vivo in rabbits with
acute femoral artery occlusion resulted in a significant 60%
increase of maximum collateral conductance 7 days after
gene transfer when compared to LacZ control, which repre-
sents a partial substitution of the effect of AV-Shunt treat-
ment. The maximum dose (41010 ifu) of virus, which could
be administered in the lumen of the collateral bed, led to a
2.5-fold increase of collateral Abra expression when com-
pared to sham-treated collateral arteries. This fractional
amount of the FSS provoked Abra expression (up to 7-fold)
in the shunt model improved the natural response but did not
completely achieve the full compensation of the occluded
femoral artery. In contrast, quantification of tissue perfusion
in the distal hindlimbs of Abra/ mice with femoral artery
occlusion or nontransgenic littermates by Laser Doppler
blood flow demonstrated an impaired arteriogenesis in
Abra/ mice. This was further confirmed by morphometry.
Normal capillary density in the distal hindlimb in both groups
excludes an angiogenic stimulus.
Because we found Abra strongly upregulated under condi-
tions of artificially high FSS we are currently establishing the
shunt surgery in gene-targeted mice.
The well-established abilities of Abra to activate Rho
signaling, to influence actin dynamics as well as cytoskeletal
integrity, and to initiate SRF-dependent gene transcription8
provide potential mechanisms to account for the improve-
ment of collateral growth.
We know from previous studies that the Rho-pathway is
involved in flow-related remodeling of small arteries27 and in
particular in arteriogenesis,6 because the Rho kinase blocker
Fasudil abolished the beneficial effect of shunt treatment in
rabbits. It is therefore suggestive that the Abra should play an
important role in arteriogenesis. Increased RhoA expression
in FSS-stimulated collaterals as well as in Ad_Abra–treated
collaterals support a causal connection of Abra and RhoA in
arteriogenesis.
In addition, changes in actin dynamics are hallmarks for
arteriogenesis: The phenotypic transition in smooth muscle
cells during arteriogenesis from the contractile to the syn-
thetic and proliferative state is characterized by the lack of
actin filaments, which is a result of downregulation of actin
transcription as well as the degree of actin polymerization. In
our experiments of chronically elevated FSS we prolonged
the dedifferentiated state of smooth muscle cells that is
characterized by differential expression of the actin-
(de)polymerizing proteins (destrin, cofilin1, cofilin2, and
transgelin23). A specific staining of F-actin and G-actin
supports this observation: F-actin is more fragmented,
whereas G-actin accumulates in shunt vessels compared to
sham-treated collaterals.
However, Abra promotes the formation of F-actin, and Rho
activation leads to actin polymerization. This apparent con-
tradiction corresponds with and extends previous findings
derived from forced Abra overexpression in the heart. In-
creased expression of Abra in response to stress stimuli—FSS
in our model—may initially serve as a compensatory re-
sponse to increased actin content to maintain cytoskeletal
integrity and sustain arterial function.11 But excessive expres-
sion leads to adaptation, which results in adverse cardiac
remodeling in mouse models of cardiac hypertrophy11 or, as
we could demonstrate in rat and rabbit models of FAL, to
Figure 6. Immunofluorescence confocal microscopy of collateral
vessels in rats (A and C) and mice (B) was performed 7 days
after the indicated treatments, using antibodies (A and B)
against RhoA (green) and the SMC marker SMA (red), (C)
against F-actin (green) and G-actin (green). Nuclei were counter-
stained with Draq5 (blue; scale bars40 m).
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beneficial collateral growth. Interestingly, Abra overexpres-
sion in both models is accompanied by activation of SRF-
dependent fetal cardiac genes11 (and our results from microar-
rays, supplemental Table II).
Abra initiates SRF-dependent transcription. Apart from
previous findings of SRF-dependent transcription during
arteriogenesis (reviewed in28), we were able to demon-
strate that SRF itself is upregulated under conditions of
high FSS. RhoA-dependent regulation of the actin cy-
toskeleton selectively regulates SMC differentiation
marker gene expression by modulating SRF dependent
transcription.29
The question how the signals, generated in endothelial
cells, are translated into a growth stimulus for the smooth
muscle layer of the media that is separated from the endo-
thelium by the internal elastic lamina, remains unsolved.
None of the already known endothelial stress–responsive
proteins (Klf2,30 PECAM-cadherin-VEGFR2 complex,31
Trpv424) explain the proliferation of the SMCs of the media.
We as well as others were unable to find endothelial-to-
smooth muscle junctions in collaterals,32,33 which reduce the
means of communication to diffusible transmitters, like NO,
oxygen radicals, endothelin, and diffusible factors like VEGF.
However, because monocytes play an important role in arterio-
genesis and their blockade leads to impaired arteriogenesis, NO
from iNOS may be a candidate. The blockage of all sources of
NO by L-NAME completely abolished the beneficial shunt
effect6 and resulted in significantly decreased Abra tran-
scription. These findings suggest that NO is involved in the
FSS mediation to the media and results in Abra induction,
which provides a potential explanation of the unexpected
mitogenic effect of NO.34,35
One of the earliest events in arteriogenesis is the FSS-
dependent activation of mechanosensitive transient receptor
potential cation channel, subfamily V, member 4 (Trpv4),24 a
Ca2 permeable ion channel. To further elucidate the up-
stream signaling we analyzed Abra promoters of 7 different
species including chicken and opossum in silico with geno-
matix software to find transcription factor (TF) binding sites.
Two closely spaced potential regulatory units for ATF4 and
MEF2 upstream of transcription start sites were detected
(supplemental Figure VI). The involvement of MEFs in many
muscle specific regulatory circuits36,37 and MEF2-dependent
Abra transcription has recently been shown.11 In addition we
identified a DRE-site in the rat Abra promoter that binds Kv
channel interacting protein 3 (Kcnip3, also known as Dream).
The fact that binding sites of 2 of the 3 major calcium
dependent transcriptional effectors (NFAT, MEF2, DREAM)38
are present within the Abra promoter point to a potential
Ca2-dependent regulation. In a recently published microar-
ray analysis of gene expression in mouse aorta an involve-
ment of the calcium signaling pathway was demonstrated for
the process of atherosclerosis. In this context Ca2 seems to
be involved in the monocyte chemoattractant protein-1 pro-
duction,39 which is a prerequisite for arteriogenesis as
well.5,40
Taken together, our data suggest a functional implication
of Abra for arteriogenesis. We showed an FSS-dependent
upregulation of Abra in collateral vessels and a functional
consequence for collateral growth. The previously described
features of Abra were, in most instances, extended to arterio-
genesis. Finally we propose a position for the novel arterio-
genesis gene in the existing arteriogenesis pathways as being
a link between the mechanical stimulus of FSS and the
proliferation of SMCs, thus contributing to a more compre-
hensive understanding of the process.
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